Close

Coherus BioSciences' (CHRS) Neulasta BLA Accepted by U.S. FDA

October 7, 2016 5:58 AM EDT Send to a Friend
Coherus BioSciences, Inc. (Nasdaq: CHRS) announced that the U.S. FDA has accepted the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login